Orum Therapeutics, Inc. (KOSDAQ:475830)

Orum Therapeutics Statistics

Total Valuation

KOSDAQ:475830 has a market cap or net worth of KRW 486.70 billion. The enterprise value is 354.94 billion.

Market Cap	486.70B
Enterprise Value	354.94B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:475830 has 21.07 million shares outstanding. The number of shares has increased by 15.33% in one year.

Current Share Class	21.07M
Shares Outstanding	21.07M
Shares Change (YoY)	+15.33%
Shares Change (QoQ)	+7.69%
Owned by Insiders (%)	16.53%
Owned by Institutions (%)	23.04%
Float	14.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.29
PB Ratio	3.01
P/TBV Ratio	3.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-29.07
EV / Sales	16.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-25.88

Financial Position

The company has a current ratio of 28.33, with a Debt / Equity ratio of 0.17.

Current Ratio	28.33
Quick Ratio	28.02
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	-1.95
Interest Coverage	-6.09

Financial Efficiency

Return on equity (ROE) is -8.39% and return on invested capital (ROIC) is -4.08%.

Return on Equity (ROE)	-8.39%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-4.08%
Return on Capital Employed (ROCE)	-6.03%
Revenue Per Employee	1.04B
Profits Per Employee	-610.55M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, KOSDAQ:475830 has paid 425.36 million in taxes.

Income Tax	425.36M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	20,236.40
200-Day Moving Average	n/a
Relative Strength Index (RSI)	57.32
Average Volume (20 Days)	172,211

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:475830 had revenue of KRW 20.89 billion and -12.21 billion in losses. Loss per share was -952.24.

Revenue	20.89B
Gross Profit	20.89B
Operating Income	-11.21B
Pretax Income	-11.79B
Net Income	-12.21B
EBITDA	-8.16B
EBIT	-11.21B
Loss Per Share	-952.24

Balance Sheet

The company has 158.45 billion in cash and 26.70 billion in debt, giving a net cash position of 131.76 billion or 6,253.51 per share.

Cash & Cash Equivalents	158.45B
Total Debt	26.70B
Net Cash	131.76B
Net Cash Per Share	6,253.51
Equity (Book Value)	161.79B
Book Value Per Share	7,728.98
Working Capital	155.02B

Cash Flow

In the last 12 months, operating cash flow was -12.47 billion and capital expenditures -1.25 billion, giving a free cash flow of -13.72 billion.

Operating Cash Flow	-12.47B
Capital Expenditures	-1.25B
Free Cash Flow	-13.72B
FCF Per Share	-651.04

Margins

Gross margin is 99.99%, with operating and profit margins of -53.68% and -58.45%.

Gross Margin	99.99%
Operating Margin	-53.68%
Pretax Margin	-56.41%
Profit Margin	-58.45%
EBITDA Margin	-39.07%
EBIT Margin	-53.68%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:475830 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.33%
Shareholder Yield	n/a
Earnings Yield	-2.51%
FCF Yield	-2.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:475830 has an Altman Z-Score of 12.6.

Altman Z-Score	12.6
Piotroski F-Score	n/a